Kenshi Suzuki1, Maria-Victoria Mateos2, Meletios A Dimopoulos3, Michele Cavo4, Andrzej Jakubowiak5, Stefan Knop6, Chantal Doyen7, Paulo Paulo8, Zsolt Nagy9, Polina Kaplan10, Pour Pour11, Mark Cook12, Sebastian Grosicki13, Andre Crepaldi14, Anne Liberati15, Philip Campbell16, Tatiana Shelekhova17, Sung-Soo Yoon18, Genadi Iosava19, Mamta Garg20
1Department of Hematology, Japanese Red Cross Medical Center, 2University Hospital of Salamanca / IBSAL, 3National and Kapodistrian University of Athens, 4Institute of Hematology Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 5University of Chicago Medical Center, 6Wurzburg University Medical Center, 7Universite catholique de Louvain, 8Champalimaud Centre for the Unknown, 9Semmelweis Egyetem, 10Dnepropetrovsk City Clinical Hospital #4, Regional Hematology Center, 11University Hospital Brno, 12University Hospitals Birmingham NHS Trust, 13Department of Cancer Prevention, School of Public Health, Silesian Medical University in Katowice, 14Clinica de Tratamento E, 15Azienda Ospedaliera "Santa Maria", 16Andrew Love Cancer Centre, 17Clinic of Professional Pathology
International Journal of Myeloma 8(2): 86-86, 2018.